NCT05091021

Brief Summary

The specific aim of this observational study is to characterize changes in bone turnover makers (BTMs), bone mineral density (BMD), and bone microarchitecture in a cohort of nurses during their first year of night compared to day shift work. The hypothesis is that night shift nurses will have poorer bone health indices at one year compared to day shift nurses.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

October 25, 2021

Completed
2 days until next milestone

Study Start

First participant enrolled

October 27, 2021

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

July 30, 2025

Status Verified

May 1, 2025

Enrollment Period

4.3 years

First QC Date

September 29, 2021

Last Update Submit

July 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in change of propeptide of type 1 procollagen (P1NP) over 1 year

    Difference in change of P1NP over 1 year between the two groups (night vs. day shift nurses), as measured via bone biomarker assays (immunodiagnostic systems, chemiluminescence, immunoassay)

    From baseline up to 12 months

Secondary Outcomes (4)

  • Between-group differences in the change in osteocalcin

    From baseline up to 12 months

  • DXA-derived areal bone mineral density (aBMD) changes

    From baseline up to 12 months

  • Change in bone microarchitecture

    From baseline up to 12 months

  • Between-group differences in the change in CTX (C-telopeptide of type I collagen)

    From baseline up to 12 months

Study Arms (2)

University of Colorado Health New Nurses (Day Shift Workers)

Day shift work group nurses have greater than 50% of their shifts as day shifts.

University of Colorado Health New Nurses (Night Shift Workers)

Night shift work group nurses have greater than 50% of their shifts as night shifts.

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

We will recruit volunteers from the pool of recently graduated new nurse hires at UCH. We will target our recruitment towards units that work the night shift (floor/ICU units) or day shifts (peri-operative and operating room units).

You may qualify if:

  • Healthy, nonpregnant adults 20-50 years old who recently (≤6 months) graduated from nursing school and were hired by University of Colorado Hospital for their first nursing position
  • For women to be eligible, they must be premenopausal, not breastfeeding, not pregnant with no plans to become pregnant during the year of observation and willing/able to maintain their current method of contraception use as detailed below.
  • Willing and able to travel to/from CU-AMC for study measurements at baseline and quarterly for one full year

You may not qualify if:

  • Current smokers at baseline (or within the previous year of study).
  • Individuals who are concurrently participating in another research protocol that would influence their safe participation in this study. For example, participants involved in a study that requires blood draws or ingestion of experimental medication as this would increase the risk of participation in our study and/or compromise study results.
  • Self-reported or newly diagnosed medical condition that is still being investigated or is not under good control, including those identified on screening labs such as:
  • o Out-of-range values measured on a blood sample such as glucose, TSH, creatinine or hemoglobin, that represent clinically significant abnormalities that may jeopardize safe participation or accuracy of outcome measures, at PI discretion
  • Evaluation of Psychiatric/Psychological Suitability:
  • Inability to demonstrate a full understanding of the requirements and demands of the study.
  • Individuals who are unaware of specific psychiatric diagnoses who have a history of having been treated with antidepressants, neuroleptic medications or major tranquilizers will be excluded from study.
  • Individuals with any clinically significant sleep disorder; Diagnosis or symptoms of sleep disorders (history of significant parasomnia as an adult \[night terrors, frequent sleep walking\], insomnia, including but not limited to hypersomnias such as apnea, periodic limb movements, narcolepsy). Sleep disorders will be screened by self-report and physician interview including use of validated sleep questionnaires (PSQI, Epworth sleepiness scale, and Berlin sleep questionnaire for sleep apnea).
  • Individuals on medications known to affect bone turnover (e.g., glucocorticoids, osteoporosis medications);
  • Individuals with eGFR \< 60 mL/min/1.73m2 as this is known to affect CTX measurements.
  • Symptoms of active illness (e.g., fever) at time of enrollment; note - participant may be studied at a later date if they have not yet started their clinical duties by that time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CU Anschutz

Aurora, Colorado, 80045, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood serum, plasma

MeSH Terms

Conditions

OsteoporosisSleep Disorders, Circadian Rhythm

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesChronobiology DisordersNervous System DiseasesDyssomniasSleep Wake DisordersOccupational DiseasesMental Disorders

Study Officials

  • Christine M Swanson, MD, MCR

    CU Anschutz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2021

First Posted

October 25, 2021

Study Start

October 27, 2021

Primary Completion

February 28, 2026

Study Completion

February 28, 2026

Last Updated

July 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations